CSPC says FDA clears CRB-701 pivotal trial in second-line oropharyngeal cancer
CSPC PHARMA HA1406 Enteric-coated Tablets for Depression Treatment Meet Primary Endpoint in Phase III Clinical Trial
CSPC PHARMA Marketing Application for Sirolimus for Injection Accepted
Morgan Stanley Remains a Buy on CSPC Pharmaceutical Group (CHJTF)
CSPC says China NMPA accepts sirolimus albumin-bound injection filing, grants priority review
CSPC PHARMA Expects Interim Consolidated Profit of Approximately RMB5.9B-6.2B